g>, the University of Heidelberg, the
University of Bonn, the University Medical Center of Utrecht, Nijmegen
Medical Center, the University of Verona, the
Duke University Center for
Population Genomics and Pharmacogenetics and the University of Sichuan,
China. Follow up cohorts included those from Aarhus University, the National
Serum Institute, and Bispebjerg and Glostrup hospitals, Denmark; Semmelweis
University, Budapest; the Mental Health Research Center of the Russian
Academy of Sciences; the Universities of Valencia and Santiago de Compostela,
and the Hospital General Universitario Gregorio Maranon, Madrid, Spain; The
Northern Finland Birth Cohort;
Karolinska Institutet, Stockholm; Universities
of Amsterdam, Utrecht and Maastricht, the Netherlands. The institutions
comprising the ISC and MGS can be found in papers published concurrently with
the present study in the online edition of Nature.
Funding for the work included in this study was provided by the European
Union through the SGENE consortium (www.SGENE.eu), by grants
LSHM-CT-2006-037761, PIAP-GA-2008-218251, and HEALTH-F2-2009-223423; The U.S.
National Institutes of Health; and the National Genomic Network of Germany.
About deCODE
deCODE is a bio-pharmaceutical company developing drugs and DNA-based
tests to improve the treatment, diagnosis and prevention of common diseases.
Its lead therapeutic programs, which leverage the company's expertise in
chemistry and structural biology, include DG041, an antiplatelet compound
being developed for the prevention of arterial thrombosis; DG051 and DG031,
compounds targeting the leukotriene pathway for the prevention of heart
attack; and DG071 and a platform for other PDE4 modulators with therapeutic
applications in Alzheimer's disease and other conditions. deCODE is a global
leader in human genetics, and has identified key variations in the genome
(SNPs) conferring increased ris
'/>"/>
SOURCE DeCODE Genetics Inc Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine technology :1.
Major deCODE-led Study Underscores Role of the Brain in Obesity2.
Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value3.
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival4.
Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary5.
Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms6.
New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations7.
UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations8.
Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients9.
Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment10.
Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin11.
St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases